AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Lodder, L Frets, PG Trijsburg, RW Tibben, A Meijers-Heijboer, EJ Duivenvoorden, HJ Wagner, A van der Meer, CA Devilee, P Cornelisse, CJ Niermeijer, MF
Citation: L. Lodder et al., Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing, EUR J HUM G, 9(7), 2001, pp. 492-500

Authors: Brekelmans, CTM Seynaeve, C Bartels, CCM Tilanus-Linthorst, MMA Meijers-Heijboer, EJ Crepin, CMG van Geel, AN Menke, M Verhoog, LC van den Ouweland, A Obdeijn, IM Klijn, JGM
Citation: Ctm. Brekelmans et al., Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk, J CL ONCOL, 19(4), 2001, pp. 924-930

Authors: Lodder, L Frets, PG Trijsburg, RW Meijers-Heijboer, EJ Klijn, JGM Duivenvoorden, HJ Tibben, A Wagner, A van der Meer, CA van den Ouweland, AMW Niermeijer, MF
Citation: L. Lodder et al., Psychological impact of receiving a BRCA1/BRCA2 test result, AM J MED G, 98(1), 2001, pp. 15-24

Authors: Wagner, A Hendriks, Y Meijers-Heijboer, EJ de Leeuw, WJF Morreau, H Hofstra, R Tops, C Bik, E Brocker-Vriends, AHJT van der Meer, C Lindhout, D Vasen, HFA Breuning, MH Cornelisse, CJ van Krimpen, C Niermeijer, MF Zwinderman, AH Wijnen, J Fodde, R
Citation: A. Wagner et al., Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutchpedigree, J MED GENET, 38(5), 2001, pp. 318-322

Authors: Verhoog, LC Berns, EMJJ Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients, J CL ONCOL, 18(21), 2000, pp. 119S-124S

Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, LANCET, 355(9220), 2000, pp. 2015-2020

Authors: Lodder, LN Frets, PG Trijsburg, RW Meijers-Heijboer, EJ Klijn, JGM Niermeijer, MF
Citation: Ln. Lodder et al., Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands, J MED GENET, 37(11), 2000, pp. 883-884

Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation, GYNAKOLOGE, 33(10), 2000, pp. 768-769

Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer, BR J CANC, 83(3), 2000, pp. 384-386

Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Dahmen, G van Geel, AN Bartels, CCM Tilanus-Linthorst, MMA Wagner, A Devilee, P Halley, DJJ van den Ouweland, AMW Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Survival in hereditary breast cancer associated with germline mutations ofBRCA2, J CL ONCOL, 17(11), 1999, pp. 3396-3402

Authors: Lodder, LN Frets, PG Trijsburg, RW Meijers-Heijboer, EJ Klijn, JGM Duivenvoorden, HJ Tibben, A Wagner, A van der Meer, CA Devilee, P Cornelisse, CJ Niermeijer, MF
Citation: Ln. Lodder et al., Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?, J MED GENET, 36(12), 1999, pp. 906-913
Risultati: 1-11 |